Various degradative enzymes, either in the tumor cells or in host cells, are induced to do so by tumor-derived factors related to retinoid signaling such as RAI2 or through retinoid-independent metastasis modulators such as WRN, IGF1-R, TGF-β1 and E-cadherin. The gene discussed is IGF1R; the disease is neoplasm.